Alyeska Investment Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,000
| Closed | -$649K | – | 534 |
|
|
2024
Q4 | $649K | Hold |
100,000
| – | – | ﹤0.01% | 508 |
|
|
2024
Q3 | $554K | Hold |
100,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q2 | $558K | Hold |
100,000
| – | – | ﹤0.01% | 463 |
|
|
2024
Q1 | $671K | Hold |
100,000
| – | – | ﹤0.01% | 404 |
|
|
2023
Q4 | $912K | Hold |
100,000
| – | – | 0.01% | 377 |
|
|
2023
Q3 | $552K | Hold |
100,000
| – | – | ﹤0.01% | 427 |
|
|
2023
Q2 | $854K | Hold |
100,000
| – | – | 0.01% | 428 |
|
|
2023
Q1 | $919K | Hold |
100,000
| – | – | 0.01% | 373 |
|
|
2022
Q4 | $1.02M | Hold |
100,000
| – | – | 0.01% | 346 |
|
|
2022
Q3 | $1.47M | Hold |
100,000
| – | – | 0.02% | 330 |
|
|
2022
Q2 | $1.07M | Hold |
100,000
| – | – | 0.01% | 459 |
|
|
2022
Q1 | $1.08M | Buy |
+100,000
| New | +$1.08M | 0.01% | 489 |
|
|
2021
Q4 | – | Sell |
-75,000
| Closed | -$1.61M | – | 630 |
|
|
2021
Q3 | $1.61M | Buy |
+75,000
| New | +$1.61M | 0.02% | 531 |
|